Teck Resources Ltd (USA) (NYSE:TCK)
On Wednesday, Teck Resources Ltd (USA) (NYSE:TCK)’s shares inclined 0.85% to $4.72.
TCK has 73.70% institutional ownership while its EPS ratio was -2.46. The company has 566.80 million shares outstanding while market capitalization of the company was $2.72 billion. Price to book ratio was 0.21. Net profit margin of the company was -22.90% while gross profit margin was 16.90%. Stock volatility for the month was booked as 6.74% while for the week was recorded as 7.53%.
The mean estimate for the short term price target for Teck Resources Ltd (USA) (TCK) stands at $8.32 according to 23 Analysts. The higher price target estimate for the stock has been calculated at $13.58 while the lower price target estimate is at $4.53.
Analysts mean recommendation for the stock is 2.80. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Teck Resources Limited is engaged in the business of exploring, acquiring, developing and producing natural resources. The Company is focused on steelmaking coal, copper, zinc and energy.
Merck & Co., Inc. (NYSE:MRK)
Merck & Co., Inc. (NYSE:MRK)’s shares gained 0.97% to $54.23.
MRK has the market capitalization of $150.04 billion. The stock has P/B ratio of 3.35 while EPS was $3.75. Institutional ownership of the company was 76.30% while 2.79 billion shares were outstanding. Net profit margin of the Company was 27.10% while its gross profit margin was 63.70%. Share of the company moved above its SMA 50 with 4.05%. ROE ratio was 22.90% while ROI was 0.50%.
The mean estimate for the short term price target for Merck & Co., Inc. (MRK) stands at $62.53 according to 17 Analysts. The higher price target estimate for the stock has been calculated at $72.00 while the lower price target estimate is at $54.00.
Analysts mean recommendation for the stock is 2.40. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products, which it markets directly and through its joint ventures.
Alcatel Lucent SA (ADR) (NYSE:ALU)
At the end of Wednesday’s trade, Alcatel Lucent SA (ADR) (NYSE:ALU)‘s shares surged 1.02% to $3.97.
ALU has market capitalization of $11.25 billion. Its current ratio was 1.40 while its shares were above its 50 days simple moving average with 6.46%. The company offered earning per share of $-0.05 while its 2.80 billion shares were outstanding. YTD performance of the company was 11.83%. Stock volatility for the week was 1.85% while for the month it was shown at 1.58%.
The mean estimate for the short term price target for Alcatel Lucent SA (ADR) (ALU) stands at $4.39 according to 7 Analysts. The higher price target estimate for the stock has been calculated at $5.69 while the lower price target estimate is at $3.75.
Analysts mean recommendation for the stock is 2.60. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Alcatel Lucent is a provider of Internet protocol (IP) and cloud networking and ultra-broadband access. The Company operates through Core Networking and Access segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.